The total return over the past 12 months is +89.15% vs. +16.94% for the S&P 500. So far it's up +41.18% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +89.15% | +91.11% | +12.31% | N/A | N/A | N/A |
| Total Return CAGR | +89.15% | +91.11% | +12.31% | N/A | N/A | N/A |
| Revenue CAGR | +134.82% | +26.65% | +10.22% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Kymera Therapeutics, Inc. (KYMR)
| Year | Start price | End price | KYMR Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $77.81 | $109.85 | +41.18% | +14.51% | +26.67% |
| 2025 | $40.23 | $77.81 | +93.41% | +17.72% | +75.69% |
| 2024 | $25.46 | $40.23 | +58.01% | +24.89% | +33.12% |
| 2023 | $24.96 | $25.46 | +2.00% | +26.19% | (24.19%) |
| 2022 | $63.49 | $24.96 | (60.69%) | (18.17%) | (42.52%) |
| 2021 | $62.00 | $63.49 | +2.40% | +28.74% | (26.34%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
